Medical–surgical integration ‘boosts neoadjuvant chemotherapy use for bladder cancer’
Research from the USA indicates that a multidisciplinary approach and coordination between medical and surgical oncology services can help optimize the use of neoadjuvant chemotherapy for bladder cancer.
Source: MedWire News - Oncology - Category: Cancer & Oncology Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy